The MYC oncogene — the grand orchestrator of cancer growth and immune evasion
R Dhanasekaran, A Deutzmann… - Nature reviews Clinical …, 2022 - nature.com
The MYC proto-oncogenes encode a family of transcription factors that are among the most
commonly activated oncoproteins in human neoplasias. Indeed, MYC aberrations or …
commonly activated oncoproteins in human neoplasias. Indeed, MYC aberrations or …
Paraganglioma and phaeochromocytoma: from genetics to personalized medicine
J Favier, L Amar, AP Gimenez-Roqueplo - Nature Reviews …, 2015 - nature.com
Paragangliomas and phaeochromocytomas are neuroendocrine tumours whose
pathogenesis and progression are very strongly influenced by genetics. A germline mutation …
pathogenesis and progression are very strongly influenced by genetics. A germline mutation …
Short tandem repeats bind transcription factors to tune eukaryotic gene expression
CA Horton, AM Alexandari, MGB Hayes, E Marklund… - Science, 2023 - science.org
Short tandem repeats (STRs) are enriched in eukaryotic cis-regulatory elements and alter
gene expression, yet how they regulate transcription remains unknown. We found that STRs …
gene expression, yet how they regulate transcription remains unknown. We found that STRs …
The genetic changes of Wilms tumour
TD Treger, T Chowdhury, K Pritchard-Jones… - Nature Reviews …, 2019 - nature.com
Wilms tumour is the most common renal malignancy of childhood. The disease is curable in
the majority of cases, albeit at considerable cost in terms of late treatment-related effects in …
the majority of cases, albeit at considerable cost in terms of late treatment-related effects in …
Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity
PLM Dahia - Nature Reviews Cancer, 2014 - nature.com
The neuroendocrine tumours pheochromocytomas and paragangliomas carry the highest
degree of heritability in human neoplasms, enabling genetic alterations to be traced to …
degree of heritability in human neoplasms, enabling genetic alterations to be traced to …
Advances in the translational genomics of neuroblastoma: From improving risk stratification and revealing novel biology to identifying actionable genomic alterations
Neuroblastoma is an embryonal malignancy that commonly affects young children and is
remarkably heterogenous in its malignant potential. Recently, the genetic basis of …
remarkably heterogenous in its malignant potential. Recently, the genetic basis of …
[HTML][HTML] Stabilization of the Max homodimer with a small molecule attenuates Myc-driven transcription
NB Struntz, A Chen, A Deutzmann, RM Wilson… - Cell chemical …, 2019 - cell.com
The transcription factor Max is a basic-helix-loop-helix leucine zipper (bHLHLZ) protein that
forms homodimers or interacts with other bHLHLZ proteins, including Myc and Mxd proteins …
forms homodimers or interacts with other bHLHLZ proteins, including Myc and Mxd proteins …
Recent achievements and current trajectories of diversity-oriented synthesis
CJ Gerry, SL Schreiber - Current Opinion in Chemical Biology, 2020 - Elsevier
For two decades, diversity-oriented synthesis (DOS) has facilitated the assembly of small-
molecule libraries comprising a variety of complex molecular architectures. Here, we …
molecule libraries comprising a variety of complex molecular architectures. Here, we …
c-Myc modulation and acetylation is a key HDAC inhibitor target in cancer
A Nebbioso, V Carafa, M Conte, FP Tambaro… - Clinical Cancer …, 2017 - AACR
Abstract Purpose: Histone deacetylase inhibitors (HDACi) are promising anticancer drugs.
Although some HDACi have entered the clinic, the mechanism (s) underlying their tumor …
Although some HDACi have entered the clinic, the mechanism (s) underlying their tumor …
DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies
Molecular subclassification is rapidly informing the clinical management of
medulloblastoma. However, the disease remains associated with poor outcomes and …
medulloblastoma. However, the disease remains associated with poor outcomes and …